洪逸平醫師詳細介紹

國立陽明大學臨床醫學研究所博士

國立臺灣大學醫學系醫學士

-迄今臺北榮民總醫院腫瘤醫學部 腫瘤內科主治醫師

2021-迄今國立陽明大學醫學院助理教授

2021-迄今臺北榮民總醫院人體試驗委員會審查委員

2021-迄今臺北榮民總醫院臨床研究受試者保護中心副執行秘書

-科技部選送博士創新之星LEAP計畫

-美國史丹佛大學化工系及癌症中心訪問學者

-國立陽明大學醫學系 內科學科講師

-臺北榮民總醫院內科部 腫瘤科住院總醫師

-臺北榮民總醫院內科部 血液科總醫師

-臺北榮民總醫院內科部住院醫師

消化系統癌症診斷治療、癌症免疫治療及細胞治療、癌症臨床試驗發起及執行

腫瘤內科專科醫師、血液病專科醫師、內科專科醫師

Shin-Yi Chung*, Yi-Ping Hung*, Yi-Ru Pan, Yu-Chan Chang, Chiao-En Wu, Dennis Shin-Shian Hsu, Peter Mu-Hsin Chang, Meng-Lun Lu, Chi-Ying F Huang, Yeu Su, Michael Hsiao, Chun-Nan Yeh, Ming-Huang Chen. Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway. Biomedicines 2021 Jul 24;9(8):885 (IF 5.61)

Yi-Ping Hung, Yu-Yun Shao, Chiun Hsu, Chih-Hung Hsu, Jan-Mou Lee, Muh-Hwa Yang, Yee Chao. The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma. Journal of the Formosan Association. 2020. Online 15 December 2020. (IF: 3.282)

Yi-Ping Hung, Yu-Yun Shao, Chiun Hsu, Chih-Hung Hsu, Jan-Mou Lee, Muh-Hwa Yang, Yee Chao. Potential of Circulating Immune Cells as Biomarkers of Nivolumab Treatment Efficacy for Advanced Hepatocellular Carcinoma. J Chin Med Assoc. 2020. 84(2):144-150. (IF: 2.743)

Yi‐Ru Pan, Chiao‐En Wu, Yu‐Chao Wang, Yi‐Chen Yeh, Meng‐Lun Lu, Yi‐Ping Hung, Yee Chao, Da‐Wei Yeh, Chien‐Hsing Lin, Jason Chia‐Hsun Hsieh, Ming‐Huang Chen, Chun‐Nan Yeh. Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response. Clin Transl Immunol. 2020, 9: e1145. (IF: 7.271)

Lu L, -C, Hsu C, Shao Y, -Y, Chao Y, Yen C, -J, Shih I-L, Hung Y, -P, Chang C, -J, Shen Y, -C, Guo J, -C, Liu T, -H, Hsu C, -H, Cheng A, -L: Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma. Liver Cancer 2019;8:480-490. (IF: 11.740)

Hung YP, Chen MH, Lin JS, Hsiao CF, Shan YS, Chen YC, Chen LT, Liu TW, Li CP, Chao Y. The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients. J Chin Med Assoc. 2018 Jul;81(7):593-598. (IF: 2.743)

Chou WC, Lin PH, Yeh YC, Shyr YM, Fang WL, Wang SE, Liu CY, Chang PM, Chen MH, Hung YP, Li CP, Chao Y, Chen MH. Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors. Int J Biol Sci. 2016 Nov 25;12(12):1523-1532. (IF: 6.58)